Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Venous Thromboembolism Clinical Trials
Venous Thromboembolism clinical trials are recruiting across 81 cities. Here are the cities with the most active studies:
Venous Thromboembolism Trial Phases
27 research organizations are sponsoring venous thromboembolism trials.
About Venous Thromboembolism
Venous thromboembolism encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE), which occur when blood clots form in veins. It is a major cause of morbidity and mortality. Treatment and prevention include anticoagulant medications, compression stockings, and early mobilization.
Clinical trials are advancing new treatments for venous thromboembolism. Currently, 32 studies are recruiting a combined 311,259 participants across the United States. Research is being conducted by 27 organizations including Scott C. Woller, MD, Manuel Monreal, Mayo Clinic and 24 others.
2026 Venous Thromboembolism Research Landscape
As of July 2026, the venous thromboembolism clinical trial landscape includes 32 actively recruiting studies across 81 cities in the United States. These studies are collectively seeking 311,259 participants, with an average enrollment target of 9,727 per study.
The research spans multiple phases of development: 8 studies are in NA, 6 studies are in PHASE3, 5 studies are in PHASE2, 2 studies are in PHASE4, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some venous thromboembolism treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 27 different organizations, including Scott C. Woller, MD, Manuel Monreal, Mayo Clinic, University of Miami, Stanford University, and 22 others. The large number of sponsors reflects significant research interest and investment in venous thromboembolism treatment advancement.
Geographically, venous thromboembolism trials are most concentrated in Boston, Massachusetts (5 trials); New Haven, Connecticut (4 trials); Jacksonville, Florida (3 trials); Los Angeles, California (3 trials); Cleveland, Ohio (3 trials) and 7 other cities.
Featured Venous Thromboembolism Studies
Highlighted recruiting studies for venous thromboembolism, selected by enrollment size and research scope.
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
A new algorithm derived from only patient age and components of the complete blood count and basic metabolic panel can identify patients discharged from the hospital who may benefit from a blood thinner (called rivaroxaban) to decrease their risk of blood clots, and for whom the risk of bleeding is minimal. The purpose of this study is to evaluate the use of a pop-up alert, which will be seen by ...
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, parti...
Registry of Patients Prescribed Anticoagulation
The Gonda Vascular Center- Thrombophilia Clinic at Mayo Clinic in Rochester, Minnesota utilizes a standardized, guideline-directed, yet patient-oriented approach for treating patients diagnosed with venous thromboembolism (VTE).This study is the ongoing registry of clinical practice with standardized approach to patient assessment and therapy. As most of registries it does not have any definite nu...
Frequently Asked Questions About Venous Thromboembolism Clinical Trials
Are there venous thromboembolism clinical trials near me?
Yes, there are 32 venous thromboembolism clinical trials currently recruiting across 81+ cities in the United States, including Boston, Massachusetts; New Haven, Connecticut; Jacksonville, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a venous thromboembolism clinical trial?
To join a venous thromboembolism clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are venous thromboembolism clinical trials free?
Yes, participation in venous thromboembolism clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of venous thromboembolism treatments are being studied?
Current venous thromboembolism clinical trials are testing a range of approaches across NA (8 studies), PHASE3 (6 studies), PHASE2 (5 studies), PHASE4 (2 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 27 research organizations.
Is it safe to participate in venous thromboembolism clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov